Search the Newsreel

TherapeuticsMD Q2 Results: Net Income Falls 70% To $164 Thousand

TherapeuticsMD (NASDAQ: TXMD) reported a significant decline in its Q2 2026 financial performance, with EPS dropping 80% to $0.01 and net income falling 70% to $164 thousand. This was primarily due to decreased license revenues and a modest increase in operating expenses. The company …

TherapeuticsMD Q2 EPS drops 80% to $0.01 on sales slide

TherapeuticsMD, Inc. Q2 2026: Revenue $869K, EPS $0.01— 10-Q Summary

TherapeuticsMD, Inc. reported its Q2 2026 financial results, with revenue of $869K and diluted EPS of $0.01, showing a decrease from the prior year. The company has completed its transformation into a pharmaceutical royalty company, with revenue primarily derived from royalty and milestone payments …

TherapeuticsMD Q2 2026 License Revenue Falls to $869000

TherapeuticsMD (TXMD) reported a decline in Q2 2026 license revenue to $869,000 from $952,000 in the prior year, with net income from continuing operations also falling to $164,000. The company's operating expenses were $1.7 million, and it held $9.2 million in cash and cash …

TherapeuticsMD (TXMD) posts Q2 2026 update and weighs strategic alternatives

TherapeuticsMD (TXMD) reported its Q2 2026 financial results, revealing a net income of $164 thousand and license revenue of $869 thousand. The company has fully transitioned into a pharmaceutical royalty company, collecting royalties from licensees, and is actively exploring strategic alternatives including potential acquisition …

TherapeuticsMD to Recognize About $365K IMVEXXY Milestone in Q3

TherapeuticsMD (NASDAQ: TXMD) reported second-quarter 2026 financial results, with net income from continuing operations totaling $164 thousand. The company expects to recognize approximately $365K (CAD 500K) in revenue during the third quarter of 2026 from an IMVEXXY sales milestone achieved by Knight Therapeutics Inc. …

TXMD: Q2 2026 saw lower net income and license revenue, with strategic alternatives under evaluation

TherapeuticsMD (TXMD) experienced a decline in net income and license revenue in Q2 2026, alongside a slight increase in operating expenses. The company is actively exploring strategic alternatives due to ongoing risks from licensee performance, litigation, and market volatility. This information is based on …

Pediatrix Medical Group (MD) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 9:00 a.m. ET CALL PARTICIPANTS Chief Executive Officer - Mark Ordan Chief Financial Officer - Kasandra Rossi Full Conference Call Transcript Operator: Thank you for standing by. My name is Jordan, and I'll …

How Investors Are Reacting To MDU (MDU) Reaffirmed 2026 Earnings Guidance And New Employee Stock Plans

MDU Resources Group, Inc. reported strong Q2 2026 results with increased sales and net income, while reaffirming its full-year 2026 earnings guidance of US$0.93 to US$1.00 per share. The company also filed new shelf registrations for employee stock ownership plan offerings, aiming for deeper …

DOX Q2 Deep Dive: Agentic Strategy and aOS Platform Drive Customer Engagement

DOX Q2 Deep Dive: Agentic Strategy and aOS Platform Drive Customer Engagement Telecom software provider Amdocs (NASDAQ:DOX) met Wall Street's revenue expectations in Q2 CY2026, with sales up 2.7% year on year to $1.17 billion. Its non-GAAP profit of $1.84 per share was in …

Amdocs (DOX) Following Mixed Results And Lowered Outlook Still Looks Undervalued

Amdocs (DOX) remains undervalued despite mixed earnings and lowered profit guidance, as its fair value of $82.03 is significantly above its current trading price of $58.59. The company exhibits strong financial characteristics with recurring revenue streams, a high renewal rate for managed services, and …

MDA Space Opens MDA CHORUS™ Control Centre in Québec

New control centre marks a major milestone in operational readiness as momentum builds for constellation's launch in late 2026 MONTRÉAL, Aug. 11, 2026 /CNW/ -- MDA Space Ltd. (TSX:MDA) (NYSE:MDA), a trusted mission partner to the global defence and space industry, today officially opened …

BNP Paribas Adjusts PT on Camden Property Trust to $113 From $111, Maintains Neutral Rating

BNP Paribas has increased its price target for Camden Property Trust (CPT) to $113 from $111, while maintaining a Neutral rating on the stock. This adjustment reflects a modest positive outlook from the firm. Other analysts have also recently updated their ratings and price …

Camden Property Trust Q2 2026 Earnings: California Exit Reshapes the Story

Camden Property Trust's Q2 2026 earnings report highlighted a significant portfolio reset with the sale of its California assets for $1.625 billion. While core operating metrics still showed pressure, the company is redeploying capital into Sun Belt markets and reducing debt, aiming for better …

MDU Resources Group, Inc. (NYSE:MDU) Receives Consensus Recommendation of "Hold" from Brokerages

MDU Resources Group (NYSE:MDU) has received a consensus "Hold" rating from seven brokerages, with an average 12-month price target of $23.40, which is higher than

Cotação OUTFRONT MDADRN (O1UT34) hoje: veja preços, gráficos e notícias em Tempo Real

Pediatrix Medical Group (MD) Stock Seems Undervalued While Its 89% Return Raises Questions

Pediatrix Medical Group (MD) has seen an 89% share price return over the past year, yet its stock appears undervalued based on several valuation metrics, including a P/E ratio significantly below the healthcare sector average. Despite a recent share price drop post-earnings, the company …

Weekly Recap: Q2 adjusted OIBDA growth and Amdocs 10-year AI IT deal

Liberty Latin America Ltd. (LILA) reported Q2 revenue of approximately $1.1 billion, with adjusted OIBDA increasing by 5% and free cash flow reaching $58 million. The company also announced a 10-year IT deal with Amdocs for its Agentic OS, aiming to integrate AI-driven operations, …

InspireMD Q2 Results: Second Quarter 2026 Earnings Release Date Set

InspireMD, Inc. will release its second quarter 2026 financial results on August 17, 2026, followed by a conference call and webcast at 8:30 a.m. ET. The company, known for its CGuard Prime carotid stent system, will discuss its financial performance and operational updates, including …

TherapeuticsMD Q2 Net Income From Cont Ops US

This article is a placeholder with no content provided beyond the title. Therefore, no meaningful summary can be generated. The title suggests it would have been about TherapeuticsMD's second-quarter net income from continuing operations in the US.

Camden Property Trust stock underperforms Monday when compared to competitors

Camden Property Trust (CPT) shares fell by 2.55% to $109.08 on Monday, underperforming a generally rough day for the stock market where the S&P 500 and Dow Jones Industrial Average also saw declines. The company's stock closed 8.96% below its 52-week high of $119.81, …

InspireMD Schedules 8:30 a.m. Call to Discuss Q2 Results

InspireMD (Nasdaq: NSPR) announced it will release its second quarter 2026 financial results on Monday, August 17, 2026. The company will host a conference call and live audio webcast at 8:30 a.m. Eastern Time to discuss the results and recent highlights. Investors can participate …

BlackRock Acquires 11-Property Camden Property Trust Portfolio for $1.6B

Camden Property Trust has sold an 11-property, 3,620-unit apartment portfolio in Southern California to an investment entity managed by BlackRock for approximately $1.6 billion. The transaction marks Camden's exit from California, with proceeds used to repay short-term debt. JLL represented Camden in the sale …

MDxHealth SA (MDXH) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for MDxHealth SA (MDXH), indicating a current earnings forecast score of 7.67, ranking 275th in its industry. Analysts have set an average price target of $7.00, with most recommending a "Buy" trend. The company's expected revenue for the …

Amdocs (DOX) International Revenue Performance Explored

Have you evaluated the performance of Amdocs' (DOX) international operations during the quarter that concluded in June 2026? Considering the extensive worldwide presence of this provider of computer systems integration, analyzing the patterns in international revenues is crucial for understanding its financial resilience and …

POMDOCTOR LIMITED Highlights Healthcare Intelligence Flywheel as a Self-Reinforcing Growth Engine

POMDOCTOR LIMITED (NASDAQ: POM) has highlighted its healthcare intelligence flywheel, a self-reinforcing growth model that integrates AI, wearable devices, healthcare data, professional medical services, and insurance networks. This model aims to continuously generate incremental data, strengthen AI analytics, enhance personalization, and boost user engagement …

Camden’s California Exit and Capital Shifts Might Change The Case For Investing In Camden Property Trust (CPT)

Camden Property Trust has recently undertaken significant capital shifts, including selling its California portfolio, filing for an ESOP share registration, updating earnings guidance, and completing a share repurchase program. These strategic moves aim to reposition the company towards Sunbelt assets and reallocate capital, although …

Earnings Miss: Amdocs Limited Missed EPS By 59% And Analysts Are Revising Their Forecasts

Amdocs Limited announced its Q3 2024 earnings, missing analyst EPS estimates by 59% with reported earnings of US$0.40 per share against an expectation of US$0.97. Despite the earnings miss, revenue remained stable year-on-year at US$1.2 billion, and the company reaffirmed its full-year revenue growth …

Amdocs Limited Just Missed Earnings - But Analysts Have Updated Their Models

Amdocs Limited's shares rose 5.1% despite missing third-quarter statutory earnings estimates, though revenues were in line with predictions. Analysts have since updated their models, increasing their earnings per share estimates for 2027 to US$6.95, while revenue forecasts remain at US$4.85 billion. Despite the increased …

Should Strong Q2 Results And Reaffirmed 2026 Guidance Require Action From MDU Resources Group (MDU) Investors?

In August 2026, MDU Resources Group, Inc. reported second-quarter 2026 results showing higher sales of US$375.3 million and net income of US$21.24 million, while reaffirming full-year 2026 earnings guidance of US$0.93 to US$1.00 per share. The company also filed new shelf registrations totaling about …

Essex Property Trust, Inc. (ESS) stock price, news, quote and history

This page provides a comprehensive overview of Essex Property Trust, Inc. (ESS), an S&P 500 REIT focusing on multifamily residential properties on the West Coast. It includes real-time stock price data, historical performance, key financial metrics, analyst ratings, and comparisons with similar companies in …

Camden Property Trust (CPT) Following California Sale Looks Slightly Undervalued

Camden Property Trust (CPT) has sold its California assets for US$1.625 billion, repositioning its portfolio towards Sunbelt properties, share repurchases, and reaffirming full-year guidance. Despite recent share price improvements, the company's valuation narrative suggests it is slightly undervalued compared to a fair value of …

Is Stronger Q2 2026 EPS From Operations Altering The Investment Case For Pediatrix Medical Group (MD)?

Pediatrix Medical Group (MD) reported stronger Q2 2026 results with increased sales and net income, leading to improved EPS from continuing operations. These results, along with the company's inclusion in Russell 2000 Defensive indexes, support its investment narrative of disciplined cost control in the …

Sei Investments Co. Cuts Stock Holdings in Pediatrix Medical Group, Inc. $MD

Sei Investments Co. reduced its stake in Pediatrix Medical Group Inc. (NYSE:MD) by 19.3% in the first quarter, selling 37,564 shares and retaining 157,407 shares valued at $3.37 million. Despite institutional selling and buying from various firms, the company reported strong Q1 earnings of …

MDU Resources Group Inc (MDU) Stock News Today

This article provides current stock information for MDU Resources Group Inc (MDU), including its current price, market capitalization, P/E ratio, and recent stock performance. It notes that more news is coming soon regarding earnings, analyst ratings, and key developments. The page serves as a …

Insider Buyers At InspireMD Recover Some Losses, But Still Down US$161k

Insiders at InspireMD bought US$420.8k worth of stock over the last year, but despite a recent 14% stock gain, they are still down US$161k on their purchases. While there was some insider selling, the net insider activity over the year indicates more buying than …